Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • nans_bn
    Member
    • Mar 2011
    • 12

    het:hom distribution in case-control study

    Hello,
    I am working on case-control study and would like to understand how to calculate and interpret the hom/het ratio distribution of the minor allele. A test data generated from plink --model is as follows

    Code:
    CHR SNP A1 A2 TEST     AFF             UNAFF       P
    
    1  snp1 A1 A2 GENO     0/25/1465     0/35/1010   0.008
    
    1  snp1 A1 A2 TREND    25/2955       35/2060     0.005
    
    1  snp1 A1 A2 ALLELIC  25/2955       35/2060     0.01
    
    1  snp1 A1 A2 DOM      25/1465       35/1010     0.009
    
    1  snp1 A1 A2 REC      0/1490        0/1050      1
    
    2  snp2 A1 A2 GENO     75/230/1250   9/140/890   1.6e-05
    
    2  snp2 A1 A2 TREND    380/2730      158/1925    2.6e-03
    
    2  snp2 A1 A2 ALLELIC  380/2730      158/1925    1.0e-06
    
    2  snp2 A1 A2 DOM      305/1250      149/890     0.0004
    
    2  snp2 A1 A2 REC      75/1480       9/1035      2.2e-2
    What I assume is that snp2 shows the best p value in the recessive model so I would assume there are more homozygous alleles than expected. And snp1 shows a stronger dominant effect so there could be more heterozygous alleles. But how can I know if the distribution of aa/aA/AA is correct and this data can be analysed further?

    Thank you..
    Last edited by nans_bn; 11-26-2013, 02:24 AM.

Latest Articles

Collapse

  • mylaser
    Reply to Cancer Drug Resistance: The Lingering Barrier to Rising Survival
    by mylaser
    Kheloyaar Login: Easy Steps to Access Your Gaming Account
    One of the most searched queries today is Kheloyaar login because users want quick and secure account access.
    The process is straightforward:
    Visit the official gaming platform.
    Open the login section.
    Enter your registered details.
    Complete the required verification.
    Access your gaming dashboard.
    The Kheloyaar login process is designed to save time while maintaining account security for every...
    Today, 07:46 AM
  • SEQadmin2
    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by SEQadmin2



    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
    ...
    07-09-2026, 11:10 AM
  • SEQadmin2
    Cancer Drug Resistance: The Lingering Barrier to Rising Survival
    by SEQadmin2



    Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

    There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
    07-08-2026, 05:17 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Yesterday, 10:26 AM
0 responses
13 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-09-2026, 10:04 AM
0 responses
26 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-08-2026, 10:08 AM
0 responses
16 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-07-2026, 11:05 AM
0 responses
33 views
0 reactions
Last Post SEQadmin2  
Working...